IRIS
METRA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 24.073
AS - Asia 8.218
NA - Nord America 5.147
SA - Sud America 619
AF - Africa 146
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 38.215
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 17.813
US - Stati Uniti d'America 4.738
IT - Italia 3.176
SG - Singapore 2.708
CN - Cina 2.652
FR - Francia 2.192
BD - Bangladesh 932
HK - Hong Kong 663
VN - Vietnam 591
BR - Brasile 382
CA - Canada 224
GB - Regno Unito 203
IN - India 201
DE - Germania 190
NL - Olanda 103
AR - Argentina 78
MX - Messico 74
IQ - Iraq 68
SE - Svezia 67
FI - Finlandia 55
ES - Italia 49
TR - Turchia 49
JP - Giappone 47
PL - Polonia 47
CO - Colombia 36
PH - Filippine 36
ZA - Sudafrica 36
SA - Arabia Saudita 35
EC - Ecuador 33
ID - Indonesia 33
VE - Venezuela 30
AT - Austria 28
PK - Pakistan 28
MY - Malesia 25
DZ - Algeria 24
MD - Moldavia 24
CL - Cile 22
JM - Giamaica 21
RO - Romania 19
CR - Costa Rica 18
JO - Giordania 17
UA - Ucraina 17
EG - Egitto 16
MA - Marocco 16
NP - Nepal 16
CH - Svizzera 14
KE - Kenya 14
LT - Lituania 14
PY - Paraguay 14
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
TN - Tunisia 13
HN - Honduras 12
PR - Porto Rico 11
SV - El Salvador 11
TH - Thailandia 11
IL - Israele 10
PT - Portogallo 10
PE - Perù 9
AU - Australia 8
KR - Corea 8
DO - Repubblica Dominicana 7
GR - Grecia 7
NI - Nicaragua 7
RS - Serbia 7
AZ - Azerbaigian 6
BO - Bolivia 6
CY - Cipro 6
IE - Irlanda 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BY - Bielorussia 5
OM - Oman 5
SI - Slovenia 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
GT - Guatemala 4
LB - Libano 4
SY - Repubblica araba siriana 4
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
KZ - Kazakistan 3
LI - Liechtenstein 3
MM - Myanmar 3
SN - Senegal 3
SR - Suriname 3
VI - Stati Uniti Isole Vergini 3
BE - Belgio 2
BH - Bahrain 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DM - Dominica 2
GE - Georgia 2
IR - Iran 2
LK - Sri Lanka 2
MU - Mauritius 2
Totale 38.176
Salva come PNG Salva come JPEG
Città #
Moscow 4.053
Lauterbourg 1.752
Ashburn 1.004
San Jose 732
Singapore 729
Milan 671
Hong Kong 651
New York 609
Beijing 308
Rome 303
Santa Clara 230
Ho Chi Minh City 192
Council Bluffs 183
Los Angeles 182
Orem 176
Hanoi 148
Dallas 138
Naples 136
Bologna 128
Turin 102
Chennai 78
Brescia 77
Catania 73
Frankfurt am Main 58
Nuremberg 57
Figino 56
Bari 55
Buffalo 55
Genoa 53
Shanghai 51
Palermo 48
Toronto 47
Manchester 41
Montreal 41
São Paulo 41
Atlanta 39
Hefei 38
Da Nang 37
Denver 37
Tokyo 37
Lappeenranta 36
London 35
Mexico City 35
Florence 34
Brooklyn 30
Chicago 30
Boardman 29
Mumbai 28
Warsaw 28
Paris 27
Baghdad 26
Amsterdam 25
Houston 25
Padua 25
Verona 25
Haiphong 24
Las Vegas 23
Hangzhou 21
Seattle 21
Phoenix 20
Charlotte 19
Guangzhou 19
San Francisco 19
Cagliari 18
Pasadena 18
Princeton 18
Brugherio 17
Helsinki 17
Lawrence 17
Modena 17
Stockholm 17
Amman 16
Johannesburg 16
Poplar 16
Parma 14
San José 14
Barnet 13
Curitiba 13
Kingston 13
Miami 13
Tashkent 13
Bergamo 12
Erbil 12
Kuala Lumpur 12
Pisa 12
Quito 12
Venice 12
Biên Hòa 11
Dhaka 11
Lahore 11
Lecce 11
Munich 11
Bogotá 10
Detroit 10
Jeddah 10
Nairobi 10
North Kansas City 10
Pescara 10
Philadelphia 10
Reggio Emilia 10
Totale 14.537
Salva come PNG Salva come JPEG
Nome #
Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation 174
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 155
Impact of heart failure severity on the mortality benefit of mitral transcatheter edge-to-edge valve repair 128
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 102
H2FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation 95
Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine--short version 95
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 94
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 90
Prognostic Value of Pre-operative Atrial Fibrillation in Patients with Secondary Mitral Regurgitation Undergoing MitraClip Implantation 90
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 89
Transcatheter Edge-To-Edge Repair in COAPT-ineligible Patients: Incidence and Predictors of 2-year Good Outcome 87
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 84
Incidence, Predictors, and Prognostic Impact of New Permanent Pacemaker Implantation After TAVR With Self-Expanding Valves 82
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 80
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 79
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 76
Concomitant Transcatheter Edge-to-Edge Treatment of Secondary Tricuspid and Mitral Regurgitation: An Expert Opinion 76
2024 update in heart failure 75
Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis 74
Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair 73
Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score 70
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry 70
Global epidemiology of heart failure 69
Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities? 66
Atrial Secondary Tricuspid Regurgitation: Insights Into the EuroTR Registry 64
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 64
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart 63
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 63
Dynamic cardiomyoplasty as an effective therapy for dilated cardiomyopathy 63
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes 61
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension 60
Differences in biomarkers and molecular pathways according to age for patients with HFrEF 59
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 58
The prognostic value of the Dandel's index in patients undergoing tricuspid transcatheter edge-to-edge repair 56
Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study 54
Centralization of the ST elevation myocardial infarction care network in the Lombardy region during the COVID-19 outbreak 53
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 53
Combined evaluation of perfusion and function for the identification of viable myocardium 53
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 53
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 53
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention 52
THE INTERPLAY BETWEEN CARDIOLOGY AND DIABETOLOGY: A RENEWED COLLABORATION TO OPTIMIZE CARDIOVASCULAR PREVENTION AND HEART FAILURE MANAGEMENT 52
Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance 51
Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies 50
Transcatheter treatment of chronic mitral regurgitation with the MitraClip system: an Italian consensus statement 50
Epidemiology, pathophysiology, diagnosis and management of atrial functional mitral regurgitation: An expert opinion paper 48
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1 - epidemiology, pathophysiology, and diagnosis 48
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 48
Right Ventricular–Pulmonary Artery Coupling in Tricuspid Regurgitation: Prognostic Value and Impact of Treatment Strategy 46
The Relevance of Right Ventricular Function and Dimension in Patients Undergoing Transcatheter Tricuspid Edge-to-Edge Repair 46
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 46
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 45
COVID myocarditis: a review of the literature 45
Management of aortic stenosis and chronic heart failure: A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 45
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 45
Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial 44
Transcatheter Edge-To-Edge Mitral Valve Repair in Non-COAPT-Like Patients: Incidence and Predictors of 2-Year Good Outcome 44
Long-term changes in left ventricular mass, chamber size and function after valve replacement in patients with severe aortic stenosis and depressed ejection fraction 44
Pathophysiological pathways in patients with heart failure and atrial fibrillation 43
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 43
Emicrania, angina e ipertensione arteriosa; dai beta-bloccanti ai calcioantagonisti. La nicardipina 43
Blood pressure and intensive treatment up-titration after acute heart failure hospitalization: Insights from the STRONG-HF trial 43
Heart failure with improved versus persistently reduced left ventricular ejection fraction: A comparison of the BIOSTAT-CHF (European) study with the ASIAN-HF registry 43
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction 43
Amino acids and derivatives, a new treatment of chronic heart failure? 42
Mitral regurgitation evolution after transcatheter tricuspid valve interventions - A sub-analysis of the TriValve registry 42
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 42
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies) 41
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 41
Linee guida ESC 2021 per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico elaborate dalla Task Force per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico della Società Europea di Cardiologia (ESC) con il contributo straordinario della Heart Failure Association (HFA) dell’ESC 41
Knowledge and application of ESC/HFA guidelines in the management of advanced heart failure 41
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 41
Fisiopatologia dello scompenso cardiaco: basi per una razionale strategia terapeutica. Seconda parte: implicazioni terapeutiche 41
Left Main Spontaneous Coronary Artery Dissection: Clinical Features, Management, and Outcomes 40
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection 40
Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology 40
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 40
Impact of mitral regurgitation in patients with acute heart failure: insights from the RELAX-AHF-2 trial 40
2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 40
Acute Heart Failure: Transitioning From Symptom-Based Care to Remission 39
Cell Therapy Improves Quality-of-Life in Heart Failure: Outcomes From a Phase III Clinical Trial 39
Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure: The STRONG-HF Trial 39
Educational needs and application of guidelines in the management of patients with mitral regurgitation. A European mixed-methods study 39
Effetti cardiovascolari della ventilazione servo-adattativa (ASV) in pazienti affetti da apnee notturne e scompenso cardiaco cronico con disfunzione sistolica ventricolare sinistra 38
Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure 38
Differenti risposte agli agenti inotropi dopo terapia betabloccante a lungo termine con metoprololo o carvedilolo in pazienti con insufficienza cardiaca cronica 38
Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair 38
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 38
Kounis syndrome, a disease to know: Case report and review of the literature 38
Assessing aortic flow with doppler echocardiography in cardiogenic shock: A crucial diagnostic tool 38
[Empagliflozin and heart failure: the EMPEROR-Reduced trial] 38
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice] 38
Therapeutical approach of tricuspid regurgitation and right heart failure 38
Management of acute coronary syndromes during the COVID-19 outbreak in Lombardy: The "macro-hub" experience 38
Rationale, objectives and design of the HEart failuRe ObsErvational Study of the Polish Cardiac Society (HEROES) 38
January 2023 at a glance: focus on acute heart failure and medical therapy 37
Burst steroid therapy and quality of life in patients with acute heart failure: Insights from the CORTAHF trial 37
[Heart rate and outcome in patients with acute and chronic heart failure] 37
Effect of Spironolactone on Left Ventricular Ejection Fraction and Volumes in Patients With Class I or II Heart Failure 37
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry 37
Totale 5.619
Salva come PNG Salva come JPEG
Categoria #
all - tutte 227.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 2 0 0 3 0 3 2 0 2 0 1 2
2022/2023113 35 16 5 1 3 12 11 12 5 2 2 9
2023/2024134 19 4 12 10 11 13 3 16 0 6 16 24
2024/2025470 42 9 9 19 9 40 57 86 87 51 27 34
2025/202640.439 101 118 119 225 375 5.117 5.418 4.137 18.131 3.540 1.900 1.258
Totale 41.185